"Cord Blood Stem Cell Banking has emerged as new opportunity of healthcare services provider in Indian market. The market is still in nascent stage of development and valued around US$ 60 Million in 2013 and further expected to surpass US$ 400 Million by 2018. The current cord blood stem cell preservation level for new born baby is below 1% and hence there exists immense opportunity for cord blood stem cell preservation service providers to grow exponentially in coming years. With more than 20 million births every year there exist ample market opportunity for large number of cord blood stem cells banks to enter Indian stem cell preservation market and expand their services portfolio. The market potential of cord blood stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1% which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new born babies. Many factors have actively contributing towards this overwhelming success cord blood stem cell banking in India and one of the major reasons for its success has been collaborations. Apart from handling the main stage single handedly, much collaboration both national and international has come to meet this upsurge. Growth in this sector can further be enhanced based on increased percolation of the middle class, which is thought to possess largest spending power, defined regulatory framework to help ensure that ethics and morals are well considered and complicate is ensured for maintaining quality parameters. India is poised to emerge as the largest source for umbilical cord blood given the very high birth rate in the world. Since umbilical cords are the richest source of stem cells, it's no surprise then that leading stem cell banking companies are keen on shifting their stem cell bases in India. Till date around six major private players, both Indian as well subsidiaries of international companies are operating in the stem cell banking market of India. “India Cord Blood Stem Cell Banking Market” research report outlines following aspects related to booming stem cell banking in India: • India Stem Cell Research & Therapy Market Overview • Cord Blood Stem Cell Banking Market Overview • Market Dynamics & Cost Analysis • Future Growth Avenues • Preferred Business Model for Cord Blood Stem Cell Banks • Regulatory & Policy Framework • Institutional Support Framework • Competitive Landscape "

1. India Cord Blood Stem Cell Banking Market
Cord Blood Stem Cell Banking has emerged as new opportunity of healthcare services provider
in Indian market. The market is still in nascent stage of development and valued around US$
60 Million in 2013 and further expected to surpass US$ 400 Million by 2018. The current cord
blood stem cell preservation level for new born baby is below 1% and hence there exists
immense opportunity for cord blood stem cell preservation service providers to grow
exponentially in coming years. With more than 20 million births every year there exist ample
market opportunity for large number of cord blood stem cells banks to enter Indian stem cell
preservation market and expand their services portfolio. The market potential of cord blood
stem cell banking in India is valued at more than US$ 350 Million at preservation level of 1%
which can increase to more than US$ 1 Billion at stem cell preservation level of 3% for new
born babies.
Many factors have actively contributing towards this overwhelming success cord blood stem
cell banking in India and one of the major reasons for its success has been collaborations.
Apart from handling the main stage single handedly, much collaboration both national and
international has come to meet this upsurge. Growth in this sector can further be enhanced
based on increased percolation of the middle class, which is thought to possess largest
spending power, defined regulatory framework to help ensure that ethics and morals are well
considered and complicate is ensured for maintaining quality parameters.
India is poised to emerge as the largest source for umbilical cord blood given the very high
birth rate in the world. Since umbilical cords are the richest source of stem cells, it's no
surprise then that leading stem cell banking companies are keen on shifting their stem cell
bases in India. Till date around six major private players, both Indian as well subsidiaries of
international companies are operating in the stem cell banking market of India.
“India Cord Blood Stem Cell Banking Market” research report outlines following aspects
related to booming stem cell banking in India:
India Stem Cell Research & Therapy Market Overview
 Cord Blood Stem Cell Banking Market Overview
 Market Dynamics & Cost Analysis

2.  Future Growth Avenues
 Preferred Business Model for Cord Blood Stem Cell Banks
 Regulatory & Policy Framework
 Institutional Support Framework
 Competitive Landscape
For Report Sample Contact: avinash@kuickresearch.com
Table of Contents
1. India Stem Cell Research & Therapy Market Overview
2. India Cord Blood Stem Cell Banking Market Overview
2.1 Current Market Scenario
2.2 Cord Blood Banking
2.3 Menstrual Blood Banking
3. Cord Blood Stem Cell Banking Market Dynamics
3.1 Cost Analysis
3.2 Issues to be Resolved
3.3 Future Growth Avenues
4. India Focused Business Model for Cord Blood Stem Cell Banks
4.1 Public Private Partnership
4.2 In-House Stem Cell Banks by Hospitals
4.3 Tie Up with Hospital Chains

3. 4.4 Stand Alone Stem Cell Banks
5. Regulatory & Policy Framework
5.1 Past (2007) - Guidelines for Stem Cell Research and Therapy
5.2 Present (2012) - Guidelines for Stem Cell Research
5.3 2012 Guidelines: At a Glance
6. Institutional Support Framework
6.1 Centre for Stem Cell Research
6.2 Indian Council of Medical Research
6.3 Department of Biotechnology
7. Competitive Landscape
7.1 LifeCell
7.2 Cryobank India
7.3 CordLife
7.4 Unistem
7.5 ReliCord